Therapeutic apheresis during pregnancy: A single center experience

• Published in: Transfusion and apheresis science 2019-10, Vol.58 (5), p.652-658
• Main Authors: Colpo, Anna, Marson, Piero, Pavanello, Francesca, Tison, Tiziana, Gervasi, Maria Teresa, Zambon, Alessandra, Ruffatti, Amelia, De Silvestro, Giustina, Hoxha, Ariela
• Format: Article
• Language: English
• Subjects: Adult; Antiphospholipid syndrome; Autoimmune congenital heart block; Female; Health technology assessment; Humans; Immunoadsorption; Plasma Exchange; Pregnancy; Pregnancy Complications - blood; Pregnancy Complications - therapy; Pregnancy Outcome; Retrospective Studies; Therapeutic apheresis
• ISSN: 1473-0502; 1878-1683
• DOI: 10.1016/j.transci.2019.07.009

Therapeutic apheresis (TA) represents a treatment option for pre-existing conditions or diseases occurring during gestation. Although pregnancy is not a contraindication per se, due to the lack of evidence-based guidelines and presumed risk of maternal/fetal adverse events there is a general resistance to its application. Between January 2005 and August 2017, at the Apheresis Unit of the University Hospital of Padua 936 TA procedures were performed during 57 pregnancies in 48 patients: 813 Plasma Exchange sessions, 119 Immunoadsorptions, 4 Red Blood Cell exchanges. The treated disease were as follows: antiphospholipid syndrome (18 patients), autoimmune congenital heart block (18), myasthenia gravis (3), Rh alloimmunization (2), systemic sclerosis (1), suspected autoimmune encephalitis (1), severe hypertriglyceridaemia (1), post partum hemolytic-uremic syndrome (1), sickle cell disease (1), lupus nephritis (1) and thrombotic thrombocytopenic purpura (1). In the time period considered the apheresis sessions applied to pregnant women were 7.1% of the total (n = 13.251). The median age at the first treatment was 33 years. The median week of gestation (WG) at the beginning of treatments was 21. Twenty (2.1%) sessions were complicated by adverse events, none requiring or prolonging hospitalization. There were 50 live births, 5 spontaneous abortions and 2 voluntary terminations of pregnancy. Median WG at delivery was 35 and caesarean section was performed in 46 cases. Our data showed that TA in pregnancy is well tolerated. Close collaboration between clinician, obstetrician and TA specialist is crucial to ensure a good outcome of high-risk pregnancies.